News

04/02/2022

Nanoligent, Sant Pau’s spin-off, raises €1M in series seed financing

Nanoligent SL, a biotech company spin-off of the Sant Pau Research Institute and Universitat Autònoma de Barcelona specialized in the development of nanotechnology-based cancer treatments, today anno...

20/12/2021

Patients with stroke and COVID-19 have more severe strokes and higher mortality

A multicenter study, led by neurologists at the Research Instituto of the Sant Pau Hospital and with the participation of the main Catalan hospitals, analyses the relationship between stroke and COVID...

24/11/2021

The UAB – IR Sant Pau Joint Research Unit in Genomic Medicine begins its activity

The Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, the Autonomous University of Barcelona and the Private Foundation Hospital de la Santa Creu i Sant Pau make possible ...

28/09/2021

Sant Pau and the Catalan oil PDOs collaborate in a research project on Mediterranean diet and fertility

The Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau - IIB Sant Pau, the Hospital de la Santa Creu i Sant Pau, and the Fundació Puigvert presented a pioneer scientific project that inclu...

09/09/2021

The UpPriority tool shows its usefulness to prioritize the updating of questions in clinical guidelines

A team of researchers from the Ibero-American Cochrane Center and the IIB Sant Pau, in collaboration with other national and international authors, has shown the usefulness of the UpPriority tool to i...